The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36

다국어 초록 (Multilingual Abstract)

Inhibition of CD36, a fatty acid transporter, has been reported to prevent glucotoxicity and ameliorate high glucose induced beta cell dysfunction. Ezetimibe is a selective cholesterol absorption inhibitor that blocks Niemann Pick C1-like 1 protein, but may exert its effect through suppression of CD36. We attempted to clarify the beneficial effect of ezetimibe on insulin secreting cells and to determine whether this effect is related to change of CD36 expression. mRNA expression of insulin and CD36, intracellular peroxide level and glucose stimulated insulin secretion (GSIS) under normal (5.6 mM) or high glucose (30 mM) condition in INS-1 cells and primary rat islet cells were compared. Changes of the aforementioned factors with treatment with ezetimibe (20 μM) under normal or high glucose condition were also assessed. mRNA expression of insulin was decreased with high glucose, which was reversed by ezetimibe in both INS-1 cells and primary rat islets. CD36 mRNA expression was increased with high glucose, but decreased by ezetimibe in INS-1 cells and primary rat islets. Three-day treatment with high glucose resulted in an increase in intracellular peroxide level; however, it was decreased by treatment with ezetimibe.
Decrease in GSIS by three-day treatment with high glucose was reversed by ezetimibe.
Palmitate uptake following exposure to high glucose conditions for three days was significantly elevated, which was reversed by ezetimibe in INS-1 cells. Ezetimibe may prevent glucotoxicity in pancreatic β-cells through a decrease in fatty acid influx via inhibition of CD36.

참고문헌 (Reference)

1 Dalgaard LT, "Suppression of FAT/CD36 mRNA by human growth hormone in pancreatic β-cells" 410 : 345-350, 2011

2 Eitel K, "Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells" 52 : 991-997, 2003

3 Leung N, "Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men" 47 : 204-213, 2004

4 Lupi R, "Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated" 51 : 1437-1442, 2002

5 Altmann SW, "Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption" 303 : 1201-1204, 2004

6 Giacca A, "Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies" 300 : E255-E262, 2011

7 Jacqueminet S, "Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration" 49 : 532-536, 2000

8 Nomura M, "Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance" 297 : E1030-E1038, 2009

9 Kim YW, "Inhibition of fatty acid translocase cluster determinant 36 (CD36), stimulated by hyperglycemia, prevents glucotoxicity in INS-1 cells" 420 : 462-466, 2012

10 김지원, "Glucolipotoxicity in Pancreatic β-Cells" 대한당뇨병학회 35 (35): 444-450, 2011

11 Poitout V, "Glucolipotoxicity : fuel excess and beta-cell dysfunction" 29 : 351-366, 2008

12 Kharroubi I, "Free fatty acids and cytokines induce pancreatic β-cell apoptosis by different mechanisms : role of nuclear factor-kappaB and endoplasmic reticulum stress" 145 : 5087-5096, 2004

13 Hajri T, "Fatty acid transport across membranes : relevance to nutrition and metabolic pathology" 22 : 383-415, 2002

14 Noushmehr H, "Fatty acid translocase(FAT/CD36)is localized on insulin-containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion" 54 : 472-481, 2005

15 Wallin T, "Facilitation of fatty acid uptake by CD36 in insulin-producing cells reduces fatty-acid-induced insulin secretion and glucose regulation of fatty acid oxidation" 1801 : 191-197, 2010

16 Orsó E, "Ezetimib influences the expression of raft-associated antigens in human monocytes" 69 : 206-208, 2006

17 Busch AK, "Expression profiling of palmitate-and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic beta-cell function" 51 : 977-987, 2002

18 Tsunoda T, "Effects of ezetimibe on atherogenic lipoproteins and glucose metabolism in patients with diabetes and glucose intolerance" 100 : 46-52, 2013

19 Boden G, "Effects of a 48-h fat infusion on insulin secretion and glucose utilization" 44 : 1239-1242, 1995

20 Hiramitsu S, "Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load" 60 : 395-400, 2012

21 Zhong Y, "Effect of ezetimibe on insulin secretion in db/db diabetic mice" 2012 : 420854-, 2012

22 Kikuchi K, "Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia" 19 : 1093-1101, 2012

23 Piro S, "Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets : possible role of oxidative stress" 51 : 1340-1347, 2002

24 Yang SJ, "Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes" 407 : 153-157, 2011

25 Robertson RP, "Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes" 53 (53): S119-S124, 2004

26 Mina-Osorio P, "Aminopeptidase N(CD13)functionally interacts with FcgammaRs in human monocytes" 77 : 1008-1017, 2005

27 Kramer W, "Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane" 280 : 1306-1320, 2005

28 Griffin E, "A link between diabetes and atherosclerosis : glucose regulates expression of CD36 at the level of translation" 7 : 840-846, 2001

29 Paolisso G, "A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM" 38 : 1213-1217, 1995

30 Kyu Chang Won, "A Protective Role for Heme Oxygenase-1 in INS-1 Cells and Rat Islets that are Exposed to High Glucose Conditions" 대한의학회 21 (21): 418-424, 2006